Building successful life sciences companies.

With over $200 million of committed capital under management, Genesys is one of the largest Canadian-based exclusively focused on the life sciences industry. View our portfolio.

Building companies, accelerating development.

Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising life science investment opportunities.

Investor Login

Sign in to our secure investor area to receive personalized updates and information. Login now »

Recent Additions

Allergan to Acquire Naurex
DUBLIN, IRELAND and EVANSTON, IL - July 26, 2015 - Allergan plc (NYSE: AGN), a leading global pharmaceutical company,... Read more
Philips and Profound Medical Collaborate to Advance Treatment for Prostate Cancer Patients
BEST, The Netherlands and TORONTO, July 21, 2015 (GLOBE NEWSWIRE) -- Royal Philips (NYSE:PHG) (AEX:PHIA) and Profound Medical Corp. (TSXV:PRN),... Read more